Neogenomics NEO
NASDAQ NEO
$19.28 -0.13 (-0.67%)
As of: Sep 22, 2026 · 11:39 AM EDT

Neogenomics (NEO) Amortization of Deferred Charges (2010 - 2025)

Neogenomics' (NEO) quarterly Amortization of Deferred Charges came in at $9000.0 in Q4 2025, down 81.25% on a YoY basis from $48000.0 in Q4 2024, and little changed quarter-over-quarter from $9000.0 in Q3 2025.

Analysis

Neogenomics (NEO) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends

Neogenomics (NEO) has reported Amortization of Deferred Charges for 15 consecutive years, with $9000.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 81.25% year-over-year to $9000.0; the trailing twelve-month figure through Dec 2025 stood at $87000.0 (down 53.97% YoY), and the FY2025 full-year result was $87000.0, down 53.97% from the prior year.
  • Amortization of Deferred Charges steadied at $9000.0 in Q4 2025 per NEO's latest filing, from $9000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $48000.0 in Q4 2024 and bottomed at $9000.0 in Q3 2025.
  • Historically, Amortization of Deferred Charges has averaged $41050.0 across 5 years, with a median of $46000.0 in 2022.
  • The sharpest annual moves came in 2021 and 2025: Amortization of Deferred Charges surged 73.08% in 2021, then plunged 81.25% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $45000.0 in 2021, then climbed by 2.22% to $46000.0 in 2022, then changed by 0.0% to $46000.0 in 2023, then increased by 4.35% to $48000.0 in 2024, then slumped by 81.25% to $9000.0 in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $9000.0, $9000.0, and $21000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 9,000.00
Sep 30, 2025 9,000.00
Jun 30, 2025 21,000.00
Mar 31, 2025 48,000.00
Dec 31, 2024 48,000.00
Sep 30, 2024 47,000.00
Jun 30, 2024 47,000.00
Mar 31, 2024 47,000.00
Dec 31, 2023 46,000.00
Sep 30, 2023 47,000.00
Jun 30, 2023 46,000.00
Mar 31, 2023 46,000.00
Dec 31, 2022 46,000.00
Sep 30, 2022 45,000.00
Jun 30, 2022 46,000.00
Mar 31, 2022 45,000.00
Dec 31, 2021 45,000.00
Sep 30, 2021 45,000.00
Jun 30, 2021 45,000.00
Mar 31, 2021 43,000.00
API Access

Neogenomics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=NEO&period=max&api_key=YOUR_API_KEY